Caffeine use in children: What we know, what we have left to learn, and why we should worry

Neuroscience and Biobehavioral Reviews

Volumn 33, Issue 6, 2009, Pages 793-806

  Temple, Jennifer L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Addiction; Adolescents; Caffeine; Conditioning; Reinforcement; Self administration; Tolerance

Indexed keywords

CAFFEINE;

ADDICTION; BEVERAGE; BRAIN DEVELOPMENT; CROSS ALLERGY; DRUG MECHANISM; FOOD INTAKE; HUMAN; OBESITY; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; SUBSTANCE ABUSE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; BRAIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CONDITIONING (PSYCHOLOGY); DIET; DIETARY CARBOHYDRATES; DRUG TOLERANCE; HUMANS; OVERWEIGHT; REWARD; RISK-TAKING; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 67349267664     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.01.001     Document Type: Review

References (230)

1. APA. Diagnostic and Statistical Manual of Mental Disorders. Revised 4th edition (1994), American Psychiatric Association, Washington, DC
2. Advocare, 2005. Product facts and ingredient: KickStart SPARK(TM). Retrieved 26 March 2008 from http://www.advocare.com/store/images/labels/k2082.pdf.
3. Alderete E., Eskenazi B., and Sholtz R. Effect of cigarette smoking and coffee drinking on time to conception. Epidemiology 6 (1995) 403-408
4. Alpecin, 2008. Product information. Retrieved 11 November 2008 from http://www.alpecin.com/caffeine/shampoo/html.
5. Alsene K., Deckert J., Sand P., and de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28 (2003) 1694-1702
6. Ammon H.P., Bieck P.R., Mandalaz D., and Verspohl E.J. Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. Br. J. Clin. Pharmacol. 15 (1983) 701-706
7. Angelucci M.E., Vital M.A., Cesario C., Zadusky C.R., Rosalen P.L., and Da Cunha C. The effect of caffeine in animal models of learning and memory. Eur. J. Pharmacol. 373 (1999) 135-140
8. Angelucci M.E., Cesario C., Hiroi R.H., Rosalen P.L., and Da Cunha C. Effects of caffeine on learning and memory in rats tested in the Morris water maze. Braz. J. Med. Biol. Res. 35 (2002) 1201-1208
9. Astrup A., Breum L., Toubro S., Hein P., and Quaade F. The effects and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine, and placebo in obese subjects on an energy restricting diet. A double blind trial. Int. J. Obes. Relat. Metab. Disord. 16 (1992) 269-277
10. Astrup A., Toubro S., Cannon S., Hein P., Breum L., and Madsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr. 51 (1990) 759-767
11. Attwood A.S., Higgs S., and Terry P. Differential responsiveness to caffeine and perceived effects of caffeine in moderate and high regular caffeine consumers. Psychopharmacology (Berl.). 190 (2007) 469-477
12. Avena N.M., and Hoebel B.G. Amphetamine-sensitized rats show sugar-induced hyperactivity (cross-sensitization) and sugar hyperphagia. Pharmacol. Biochem. Behav. 74 (2003) 635-639
13. Avena N.M., and Hoebel B.G. A diet promoting sugar dependency causes behavioral cross-sensitization to a low-dose amphetamine. Neuroscience 122 (2003) 17-20
14. Avena N.M., Rada P., and Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci. Biobehav. Rev. 32 (2008) 20-39
15. Ball S.A. The validity of an alternative five factor measure of personality in cocaine abusers. Psychol. Assess. 7 (1995) 148-154
16. Barger-Lux M.J., Heaney R.P., and Stegman M.R. Effects of moderate caffeine intake on the calcium economy of premenopausal women. Am. J. Clin. Nutr. 52 (1990) 722-725
17. Barrett-Conner E., Chang J.C., and Edelstein S.L. Coffee-associated osteoporosis offset by daily milk consumption. The Ranch Bernado Study. JAMA 271 (1994) 280-283
18. Barry R.J., Rushby J.A., Wallace M.J., Clarke A.R., Johnstone S.J., and Zlojutro I. Caffeine effects on resting-state arousal. Clin. Neurophysiol. 116 (2005) 2693-2700
19. Bedingfield J.B., King D.A., and Holloway F.A. Cocaine and caffeine: conditioned place preference, locomotor activity, and additivity. Pharmacol. Biochem. Behav. 61 (1998) 291-296
20. Bello N.T., Lucas L.R., and Hajnal A. Repeated sucrose access influences dopamine D2 receptor density in the striatum. Neuroreport 13 (2002) 1575-1578
21. Bender A.M., Donnerstein R.L., Samson R.A., Zhu D., and Goldberg S.J. Hemodynamic effects of acute caffeine ingestion in young adults. Am. J. Cardiol. 79 (1997) 696-699
22. Bergman E.A., Massey L.K., Wise K.J., and Sherrard D.J. Effects of dietary caffeine on renal handling of minerals in adult women. Life Sci. 47 (2000) 557-564
23. Berkey C.S., Rockett H.R., Field A.E., Gillman M.W., and Colditz G.A. Sugar-added beverages and adolescent weight change. Obes. Res. 12 (2004) 778-788
24. Bernstein G.A., Carroll M.E., Crosby R.D., Perwien A.R., Go F.S., and Benowitz N.L. Caffeine effects on learning, performance, and anxiety in normal school-age children. J. Am. Acad. Child. Adolesc. Psychiatry 33 (1994) 407-415
25. Bernstein G.A., Carroll M.E., Thuras P.D., Cosgrove K.P., and Roth M.E. Caffeine dependence in teenagers. Drug Alcohol. Depend. 66 (2002) 1-6
26. Bickel W.K., Odum A.L., and Madden G.J. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology 146 (1999) 447-454
27. Blum J.W., Jacobsen D.J., and Donnelly J.E. Beverage consumption patterns in elementary school aged children across a 2-year period. J. Am. Coll. Nutr. 24 (2005) 93-98
28. Bonnet M.H., and Arand D.L. Caffeine use as a model of acute and chronic insomnia. Sleep 15 (1992) 526-536
29. Boulenger J.P., Patel J., Post R.M., Parma A.M., and Marangos P.J. Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci. 32 (1983) 1135-1142
30. Bramstedt K.A. Caffeine use by children: the quest for enhancement. Subst. Use Misuse 42 (2007) 1237-1251
31. Brockwell N.T., Eikelboom R., and Beninger R.J. Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol. Biochem. Behav. 38 (1991) 513-517
32. Broderick P., and Benjamin A.B. Caffeine and psychiatric symptoms: a review. J. Okla State Med. Assoc. 97 (2004) 538-542
33. Brody A.L., Mandelkern M.A., London E.D., Childress A.R., Lee G.S., Bota R.G., Ho M.L., Saxena S., Baxter Jr. L.R., Madsen D., and Jarvik M.E. Brain metabolic changes during cigarette craving. Arch. Gen. Psychiatry 59 (2002) 1162-1172
34. Budney A.J., Higgins S.T., Hughes J.R., and Bickel W.K. Nicotine and caffeine use in cocaine-dependent individuals. J. Subst. Abuse 5 (1993) 117-130
35. Caffeine tights, 2008. Product information. Retrieved 11 November 2008 from http://www.caffeinetights.com/.
36. Caffeine eye cream, 2008. Product information. Retrieved 11 November 2008 from http://www.makeup.com/100-pure/coffee-bean-caffeine-eye-cream/.
37. Canadian Center for Drug-free Sport, 1993. National School Survey on Drugs and Sport. Ottawa, Ontario, Canada.
38. Carlezon Jr. W.A., and Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci. 25 (2002) 610-615
39. Cauli O., and Morelli M. Caffeine and the dopaminergic system. Behav. Pharmacol. 16 (2005) 63-77
40. Chandrasekaran A. Soft-drink sales fizzle while thirst for energy sizzles. Reuters News Service (2006)
41. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., and O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 156 (1999) 11-18
42. Childs E., and de Wit H. Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl.) 185 (2006) 514-523
43. Christianson R.E., Oechsli F.W., and can den Berg B.J. Caffeinated beverages and decreased fertility. Lancet 1 (1989) 378
44. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., Schwartz G.J., Moran T.H., and Hoebel B.G. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12 (2001) 3549-3552
45. Cole K.J., Costill D.L., Starling R.D., Goodpaster B.H., Trappe S.W., and Fink W.J. Effect of caffeine ingestion on perception of effort and subsequent work production. Int. J. Sport Nutr. 6 (1996) 14-23
46. Comer A.M., Perry C.M., and Figgitt D.P. Caffeine citrate: a review of its use in apnoea of prematurity. Paediatr. Drugs 3 (2001) 61-79
47. Cornelis M.C., El-Sohemy A., and Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am. J. Clin. Nutr. 86 (2007) 240-244
48. Daval J.L., Deckert J., Weiss S.R., Post R.M., and Marangos P.J. Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia 30 (1989) 26-33
49. Davidson R.A., and Smith B.D. Caffeine and novelty: effects on electrodermal activity and performance. Physiol. Behav. 49 (1991) 1169-1175
50. Denaro C.P., Brown C.R., Jacob III P., and Benowitz N.L. Effects of caffeine with repeated dosing. Eur. J. Clin. Pharmacol. 40 (1991) 273-278
51. Deslandes A.C., Veiga H., Cagy M., Piedade R., Pompeu F., and Ribeiro P. Effects of caffeine on the electrophysiological, cognitive and motor responses of the central nervous system. Braz. J. Med. Biol. Res. 38 (2005) 1077-1086
52. Dews P.B., Curtis G.L., Hanford K.J., and O'Brien C.P. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded experiment. J. Clin. Pharmacol. 39 (1999) 1221-1232
53. Dews P.B., O'Brien C.P., and Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food Chem. Toxicol. 40 (2002) 1257-1261
54. Dlugosz L., Belanger K., Hellenbrand K., Holford T.R., Leaderer B., and Bracken M.B. Maternal caffeine consumption and spontaneous abortion: a prospective cohort study. Epidemiology 7 (1996) 250-255
55. Dulloo A.G., Geissler C.A., Horton T., Collins A., and Miller D.S. Normal caffeine consumption: influence on thermogenesis and daily exercise expenditure in lean and postobese human volunteers. Am. J. Clin. Nutr. 49 (1989) 44-50
56. Durlach P.J. The effects of a low dose of caffeine on cognitive performance. Psychopharmacology (Berl.) 140 (1998) 116-119
57. Elkins R.N., Rapoport J.L., Zahn T.P., Buchsbaum M.S., Weingartner H., Kopin I.J., Langer D., and Johnson C. Acute effects of caffeine in normal prepubertal boys. Am. J. Psychiatry 138 (1981) 178-183
58. Energyfiend website, 2008. The caffeine database. http://www.energyfiend.com/huge-caffeine-database/. Accessed on 29 September 2008.
59. Epstein L.H., Leddy J.J., Temple J.L., and Faith M.S. Food reinforcement and eating: a multilevel analysis. Psychol. Bull. 133 (2007) 884-906
60. 2 receptor genotype, and energy intake in obese and nonobese humans: erratum. Behav. Neurosci. 122 (2008) 250
61. Evans S.M., and Griffiths R.R. Caffeine tolerance and choice in humans. Psychopharmacology (Berl.) 108 (1992) 51-59
62. Evans S.M., Critchfield T.S., and Griffiths R.R. Caffeine reinforcement demonstrated in a majority of moderate caffeine users. Behav. Pharmacol. 5 (1994) 231-238
63. Falk J.L., Zhang J., Chen R., and Lau C.E. A schedule induction probe technique for evaluating abuse potential: comparison of ethanol, nicotine and caffeine, and caffeine-midazolam interaction. Behav. Pharmacol. 5 (1994) 513-520
64. Farag N.H., Vincent A.S., McKey B.S., Whitsett T.L., and Lovallo W.R. Hemodynamic mechanisms underlying the incomplete tolerance to caffeine-suppressor effect. Am. J. Cardiol. 95 (2005) 1389-1392
65. Fernandes O., Sabharwal M., Smiley T., Pastuszak A., Koren G., and Einarson T. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. Reprod. Toxicol. 12 (1998) 435-444
66. Ferreira S.E., de Mello M.T., Pompeia S., and de Souza-Formigoni M.L. Effects of energy drink ingestion on alcohol intoxication. Alcohol. Clin. Exp. Res. 30 (2006) 598-605
67. Ferster C.B., and Skinner B.F. Schedules of Reinforcement (1957), Appleton-Century-Crofts, New York
68. Finn I.B., and Holtzman S.G. Tolerance to caffeine-induced stimulation of locomotor activity in rats. J. Pharmacol. Exp. Ther. 238 (1986) 542-546
69. Flaten M.A., and Blumenthal T.D. Caffeine-associated stimuli elicit conditioned responses: an experimental model of the placebo effect. Psychopharmacology (Berl.) 145 (1999) 105-112
70. Forman E.S., Dekker A.H., Javors J.R., and Davison D.T. High-risk behaviors in teenage male athletes. Clin. J. Sport Med. 5 (1995) 36-42
71. Frary C.D., Johnson R.K., and Wang M.Q. Food sources and intakes of caffeine in the diets of persons in the United States. J. Am. Diet Assoc. 105 (2005) 110-113
72. Fredholm B.B., and Svenningsson P. Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology 61 (2003) S5-9
73. Fredholm B.B., Battig K., Holmen J., Nehlig A., and Zvartau E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
74. Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 51 (2007) 116-134
75. Fuxe K., Agnati L.F., Jacobsen K., Hillion J., Canals M., Torvinen M., Tinner-Staines B., Staines W., Rosin D., Terasmaa A., Popoli P., Leo G., Vergoni V., Lluis C., Ciruela F., Franco R., and Ferre S. Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61 (2003) S19-23
76. Garrett B.E., and Holtzman S.G. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol. Biochem. Behav. 47 (1994) 89-94
77. Garrett B.E., and Holtzman S.G. Does adenosine receptor blockade mediate caffeine-induced rotational behavior?. J. Pharmacol. Exp. Ther. 274 (1995) 207-214
78. Garrett B.E., and Griffiths R.R. The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol. Biochem. Behav. 57 (1997) 533-541
79. Garrett B.E., and Griffiths R.R. Physical dependence increases the relative reinforcing effects of caffeine versus placebo. Psychopharmacology (Berl.) 139 (1998) 195-202
80. Garrett B.E., and Griffiths R.R. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J. Pharmacol. Exp. Ther. 296 (2001) 486-494
81. Gasior M., Jaszyna M., Munzar P., Witkin J.M., and Goldberg S.R. Caffeine potentiates the discriminative-stimulus effects of nicotine in rats. Psycholpharmacology (Berl.) 162 (2002) 385-395
82. Georgiev V., Johansson B., and Fredholm B.B. Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number. Brain Res. 612 (1993) 271-277
83. Giedd J. Brain development. IX. Human brain growth. Am. J. Psychiatry 156 (1999) 4
84. Giovannucci E. Meta-analysis of coffee consumption and risk of colorectal cancer. Am. J. Epidemiol. 147 (1998) 1043-1052
85. Goldstein A., and Wallace M.E. Caffeine dependence in schoolchildren?. Exp. Clin. Psychopharmacol. 5 (1997) 388-392
86. Goldstein I.B., and Shapiro D. The effects of stress and caffeine on hypertensives. Psychosom. Med. 49 (1987) 226-235
87. 3H]cyclohexyladenosine. J. Neurosci. 2 (1982) 1230-1241
88. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4 (1993) 366-374
89. Griffiths R.R., Bigelow G.E., and Liebson I.A. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J. Pharmacol. Exp. Ther. 239 (1986) 416-425
90. Griffiths R.R., Bigelow G.E., and Liebson I.A. Reinforcing effects of caffeine in coffee and capsules. J. Exp. Anal. Behav. 52 (1989) 127-140
91. Griffiths, R.R., Brady, J.V., Bradford, L.D., 1979. Predicting the abuse liability of drugs with animal self-administration procedures: Psychomotor stimulants and hallucinogens. In: Thompson, T., Dews P.B. (Eds.), Advances in Behavioral Pharmacology. 2, 163-208.
92. Griffiths R.R., Evans S.M., Heishman S.J., Preston K.L., Sannerud C.A., Wolf B., and Woodson P.P. Low-dose caffeine physical dependence in humans. J. Pharmacol. Exp. Ther. 255 (1990) 1123-1132
93. Griffiths R.R., Evans S.M., Heishman S.J., Preston K.L., Sannerud C.A., Wolf B., and Woodson P.P. Low-dose caffeine discrimination in humans. J. Pharmacol. Exp. Ther. 252 (1990) 970-978
94. Griffiths R.R., and Mumford C.K. Caffeine: a drug of abuse?. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation in Progress (1995), Raven Press, New York 1699-1713
95. Griffiths R.R., and Vernotica E.M. Is caffeine a flavoring agent in cola soft drinks?. Arch. Family Med. 9 (2000) 727-734
96. Griffiths R.R., and Woodson P.P. Reinforcing effects of caffeine in humans. J. Pharmacol. Exp. Ther. 246 (1988) 21-29
97. Hajnal A., and Norgren R. Repeated access to sucrose augments dopamine turnover in the nucleus accumbens. Neuroreport 13 (2002) 2213-2216
98. Hale K.L., Hughes J.R., Oliveto A.H., and Higgins S.T. Caffeine self-administration and subjective effects in adolescents. Exp. Clin. Psychopharm. 3 (1995) 364-370
99. Harnack L., Stang J., and Story M. Soft drink consumption among US children and adolescents: nutritional consequences. J. Am. Diet Assoc. 99 (1999) 436-441
100. Harris S.S., and Dawson-Hughes B. Caffeine and bone loss in healthy postmenopausal women. Am. J. Clin. Nutr. 60 (1994) 573-578
101. Hart C., and Smith G.D. Coffee consumption and coronary heart disease mortality in Scottish men: a 21-year follow up study. J. Epidemiol. Comm. Health 51 (1997) 461-462
102. Haskell C.F., Kennedy D.O., Wesnes K.A., and Scholey A.B. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl.) 179 (2005) 813-825
103. Heatherley S.V., Hancock K.M., and Rogers P.J. Psychostimulant and other effects of caffeine in 9-11-year-old children. J. Child. Psychol. Psychiatry 47 (2006) 135-142
104. Hernan M.A., Takkouche B., Caamano-Isorna F., and Gestal_otero J.J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann. Neurol. 52 (2002) 276-284
105. Herrera-Marschitz M., Casas M., and Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology (Berl.) 94 (1988) 38-45
106. Higdon J.V., and Frei B. Coffee and health: a review of the recent human research. Crit. Rev. Food Sci. Nutr. 46 (2006) 101-123
107. Hogervorst E., Bandelow S., Schmitt J., Jentjens R., Oliveira M., Allgrove J., Carter T., and Gleeson M. Caffeine improves physical and cognitive performance during exhaustive exercise. Med. Sci. Sports Exerc. 40 (2008) 1841-1851
108. Horger B.A., Shelton K., and Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37 (1990) 707-711
109. Horger B.A., Wellman P.J., Morien A., Davies B.T., and Schenk S. Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2 (1991) 53-56
110. Horger B.A., Giles M.K., and Schenk S. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology (Berl.) 107 (1992) 271-276
111. Howell L.L., Coffin V.L., and Spealman R.D. Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology (Berl.) 129 (1997) 1-14
112. Hudson G.M., Green J.M., Bishop P.A., and Richardson M.T. Effects of caffeine and aspirin on light resistance training performance, perceived exertion, and pain perception. J. Strength Cond. Res. 22 (2008) 1950-1957
113. Hughes J.R., and Hale K.L. Behavioral effects of caffeine and other methylxanthines on children. Exp. Clin. Psychopharmacol. 6 (1998) 87-95
114. Hughes J.R., Higgins S.T., Bickel W.K., Hunt W.K., Fenwick J.W., Gulliver S.B., and Mireault G.C. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Arch. Gen. Psychiatry 48 (1991) 611-617
115. Hughes J.R., and Oliveto A.H. A systematic survey of caffeine intake in Vermont. Exp. Clin. Psychopharmacol. 5 (1997) 393-398
116. Hughes J.R., Oliveto A.H., Bickel W.K., Higgins S.T., and Badger G.J. The ability of low doses of caffeine to serve as reinforcers in humans: a replication. Exp. Clin. Psychopharmacol. 3 (1995) 358-363
117. Hughes J.R., Oliveto A.H., Liguori A., Carpenter J., and Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend. 52 (1998) 99-107
118. James C.E., Laing D.G., and Oram N. A comparison of the ability of 8-9-year-old children and adults to detect taste stimuli. Physiol. Behav. 62 (1997) 193-197
119. James J.E. Acute and chronic effects of caffeine on performance, mood, headache, and sleep. Neuropsychobiology 38 (1998) 32-41
120. James J.E., Gregg M.E., Kane M., and Harte F. Dietary caffeine, performance and mood: enhancing and restorative effects after controlling for withdrawal relief. Neuropsychobiology 52 (2005) 1-10
121. Jensen T.K., Henriksen T.B., Hjollund N.H., Scheike T., Kolstad H., Giwercman A., Ernst E., Bonde J.P., Skakkebaek N.E., and Olsen J. Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod. Toxicol. 12 (1998) 289-295
122. Jiang H., Jackson-Lewis V., Muthane U., Dollison A., Ferreira M., Espinosa A., Parsons B., and Przedborski S. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res. 613 (1993) 347-351
123. Johnson R.K., and Kennedy E. The 2000 dietary guidelines for Americans: what are the changes and why were they made? The Dietary Guidelines Advisory Committee. J. Am. Diet Assoc. 100 (2000) 769-774
124. Jolt Gum, 2008. Product facts and ingredients. Retrieved 11 November 2008 from http://www.joltgum.com/info_gum.html.
125. Jones G. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. Essays Biochem. 44 (2008) 109-123
126. Jones H.A., and Lejuez C.W. Personality correlates of caffeine dependence: the roles of sensation seeking, impulsivity, and risk taking. Exp. Clin. Psychopharmacol. 13 (2005) 259-266
127. Jones H.E., and Griffiths R.R. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers. Psychopharmacology (Berl.) 165 (2003) 280-290
128. Juliano L.M., and Griffiths R.R. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176 (2004) 1-29
129. Kalant, H., Khanna, J.M., 1990. Methods for the study of tolerance. In: M. Adler, A. Cowan (Eds.), Modern Methods in Pharmacology. 6, 43-66.
130. Kalivas P.W., and Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13 (1993) 266-275
131. Kendler K.S., and Prescott C.A. Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am. J. Psychiatry 156 (1999) 223-228
132. Kerrigan S., and Lindsey T. Fatal caffeine overdose: two case reports. Forens. Sci. Int. 153 (2005) 67-69
133. Kovacs E.M., Lejeune M.P., Nijs I., and Westerterp-Plantenga M.S. Effects of green tea on weight maintenance after body-weight loss. Br. J. Nutr. 91 (2004) 431-437
134. Kozlowski L.T., Henningfield J.E., Keenan R.M., Lei H., Leigh G., Jelinek L.C., Pope M.A., and Haertzen C.A. Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. J. Subst. Abuse Treat. 10 (1993) 171-179
135. Kovacs E.M., and Mela D.J. Metabolically active functional food ingredients for weight control. Obes. Rev. 7 (2006) 59-78
136. Kudlacek O., Just H., Korkhov V.M., Vartian N., Klinger M., Pankevych H., Yang Q., Nanoff C., Freissmuth M., and Boehm S. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology 28 (2003) 1317-1327
137. Kuribara H., and Uchihashi Y. Interactions of opioids with caffeine: evaluation by ambulatory activity in mice. J. Pharm. Pharmacol. 46 (1994) 141-144
138. Lane J.D., and Williams Jr. R.B. Cardiovascular effects of caffeine and stress in regular coffee drinkers. Psychophysiology 24 (1987) 157-164
139. Lejuez C.W., Aklin W.M., Jones H., Richards J.B., Strong D.R., Kahler C.W., et al. The balloon analogue risk task (BART) differentiates smokers and non-smokers. Exp. Clin. Psychopharm. 11 (2003) 26-33
140. Lejuez C.W., Read J.P., Kahler C.E., Riochards J.B., Ramsey S.E., Stuart G.L., et al. Evaluation of behavioral measure of risk-taking: the balloon analogue risk task (BART). J. Exp. Clin. Psychol.: Appl. 8 (2002) 75-84
141. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl.) 98 (1989) 357-362
142. Lieberman H.R., Wurtman R.J., Emde G.G., Roberts C., and Coviella I.L. The effects of low doses of caffeine on human performance and mood. Psychopharmacology (Berl.) 92 (1987) 308-312
143. Lopez-Garcia E., van Dam R.M., Rajpathak S., Willett W.C., Manson J.E., and Hu F.B. Changes in caffeine intake and long-term weight change in men and women. Am. J. Clin. Nutr. 83 (2006) 674-680
144. Ludwig D.S., Peterson K.E., and Gortmaker S.L. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357 (2001) 505-508
145. Mahan L.C., McVittie L.D., Smyk-Randall E.M., Nakata H., Monsma Jr. F.J., Gerfen C.R., and Sibley D.R. Cloning and expression of an A1 adenosine receptor from rat brain. Mol. Pharmacol. 40 (1991) 1-7
146. Marshall T.A., Broffitt B., Eichenberger-Gilmore J., Warren J.J., Cunningham M.A., and Levy S.M. The roles of meal, snack, and daily total food and beverage exposures on caries experience in young children. J. Public Health Dent. 65 (2005) 166-173
147. Martin C.A., Cook C., Woodring J.H., Burkhardt G., Guenthner G., Omar H.A., and Kelly T.H. Caffeine use: association with nicotine use, aggression, and other psychopathology in psychiatric and pediatric outpatient adolescents. Sci. World J. 22 (2008) 512-516
148. Miller K.E. Wired: energy drinks, jock identity, masculine norms, and risk taking. J. Am. Coll. Health 56 (2008) 481-489
149. Miller K.E. Energy drinks, race, and problem behaviors among college students. J. Adolesc. Health 43 (2008) 490-497
150. Molinengo L., Scordo I., and Pastorello B. Action of caffeine, L-PIA and their combination on memory retention in the rat. Life Sci. 54 (1994) 1247-1250
151. Molnar D., Torok K., Erhardt E., and Jeges S. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 1573-1578
152. Morgan K.J., Stults V.J., and Zabik M.E. Amount and dietary sources of caffeine and saccharin intake by individuals ages 5-18 years. Regul. Toxicol. Pharmacol. 2 (1982) 296-307
153. Nawrot P., Jordan S., Eastwood J., Rotstein J., Hugenholtz A., and Feeley M. Effects of caffeine on human health. Food Add. Contam. 20 (2003) 1-30
154. National Collegiate Athletic Association, 2006. NCAA banned drug classes 2007-2008. http://www1.ncaa.org/membership/ed_outreach/health-safety/drug_testing/b anned_drug_classes.pdf. Accessed 29 September 2008.
155. Nehlig A., Daval J.L., and Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev. 17 (1992) 139-170
156. Nehlig A. Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci. Biobehav. Rev. 23 (1999) 563-576
157. Nikodijevic O., Jacobson K.A., and Daly J.W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 44 (1993) 199-216
158. O'Brien C.P. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am. J. Psychiatry 162 (2005) 1423-1431
159. O-Brien M.C., McCoy T., Rhodes S.D., Wagoner A., and Wolfson M. Caffeinated cocktails: get wired, get drunk, get injured. Acad. Emerg. Med. 15 (2008) 453-460
160. Olsen J. Cigarette smoking, tea, and coffee drinking and subfecundity. Am. J. Epidemiol. 133 (1991) 734-739
161. Orbeta R.L., Overpeck M.D., Ramcharran D., Kogan M.D., and Ledsky R. High caffeine intake in adolescents: associations with difficulty sleeping and feeling tired in the morning. J. Adolesc. Health 38 (2006) 451-453
162. Oteri A., Salvo F., Caputi A.P., and Calapai G. Intake of energy drinks in association with alcoholic beverages in a cohort of students of the school of medicine of the University of Messina. Alcohol Clin. Exp. Res. 31 (2007) 1677-1680
163. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Kokkinos P., Toutouzas P., and Stefanadis C. The J-shaped effects of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J. Nutr. 133 (2003) 3228-3232
164. Patkina N.A., and Zvartau E.E. Caffeine place conditioning in rats: comparison with cocaine and ethanol. Eur. Neuropsychopharmacol. 8 (1998) 287-291
165. Pollak C.P., and Bright D. Caffeine consumption and weekly sleep patterns in US seventh-, eighth-, and ninth-graders. Pediatrics 111 (2003) 42-46
166. Puccio E.M., McPhillips J.B., Barrett-Connor E., and Ganiats T.G. Clustering of atherogenic behaviors in coffee drinkers. Am. J. Public Health 80 (1990) 1310-1313
167. Rapoport J.L., Elkins R., Neims A., Zahn T., and Berg C.J. Behavioral and autonomic effects of caffeine in normal boys. Dev. Pharmacol. Ther. 3 (1981) 74-82
168. Rapoport J.L., Jensvold M., Elkins R., Buchsbaum M.S., Weingartner H., Ludlow C., Zahn T.P., Berg C.J., and Neims A.H. Behavioral and cognitive effects of caffeine in boys and adult males. J. Nerv. Ment. Dis. 169 (1981) 726-732
169. Rapoport J.L., Berg C.J., Ismond D.R., Zahn T.P., and Neims A. Behavioral effects of caffeine in children. Relationship between dietary choice and effects of caffeine challenge. Arch. Gen. Psychiatry 41 (1984) 1073-1079
170. Reissig, C.J., Strain, E.C., Griffiths, R.R., 2009. Caffeinated energy drinks-a growing problem. Drug Alcohol Depend. 99, 1-10.
171. Retey J.V., Adam M., Khatami R., Luhmann U.F., Jung H.H., Berger W., and Landolt H.P. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin. Pharmacol. Ther. 81 (2007) 692-698
172. Richardson N.J., Rogers P.J., and Elliman N.A. Conditioned flavour preferences reinforced by caffeine consumed after lunch. Physiol. Behav. 60 (1996) 257-263
173. Robertson D., Wade D., Workman R., Woosley R.L., and Oates J.A. Tolerance to the humoral and hemodynamic effects of caffeine in man. J. Clin. Invest. 67 (1981) 1111-1117
174. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 Suppl. 2 (2000) S91-S117
175. Rogers P.J., Martin J., Smith C., Heatherley S.V., and Smit H.J. Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology (Berl.) 167 (2003) 54-62
176. Rosin D.L., Robeva A., Woodard R.L., Guyenet P.G., and Linden J. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J. Comp. Neurol. 401 (1998) 163-186
177. Ross G.W., Abbott R.D., Petrovitch H., White L.R., and Tanner C.M. Relationship between caffeine intake and Parkinson's disease. JAMA 283 (2000) 2674-2679
178. Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., and Hu F.B. Coffee consumption and risk for type 2 diabetes mellitus. Ann. Intern. Med. 140 (2004) 1-8
179. Salim H., Ferre S., Dalal A., Peterfreund R.A., Fuxe K., Vincent J.D., and Lledo P.M. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells. J. Neurochem. 74 (2000) 432-439
180. Satel S. Is caffeine addictive?-a review of the literature. Am. J. Drug Alcohol. Abuse 32 (2006) 493-502
181. Savoca M.R., Evans C.D., Wilson M.E., Harshfield G.A., and Ludwig D.A. The association of caffeinated beverages with blood pressure in adoelscents. Arch. Pediatr. Adolesc. Med. 158 (2004) 473-477
182. Savoca M.R., MacKey M.L., Evand C.D., Wilson M., Ludwig D.A., and Harshfield G.A. Association of ambulatory blood pressure and dietary caffeine in adolescents. Am. J. Hypertens. 18 (2005) 116-120
183. Schenk S., Valadez A., Horger B.A., Snow S., and Wellman P.J. Interactions between caffeine and cocaine in tests of self-administration. Behav. Pharmacol. 5 (1994) 153-158
184. Schuh K.J., and Griffiths R.R. Caffeine reinforcement: the role of withdrawal. Psychopharmacology (Berl.) 130 (1997) 320-326
185. Scholey A.B., and Kennedy D.O. Cognitive and physiological effects of an "energy drink": an evaluation of the whole drink and of glucose, caffeine, and herbal flavouring fractions. Psychopharmacology (Berl.) 176 (2004) 320-330
186. Schwenk T.L., and Costley C.D. When food becomes a drug: nonanabolic nutritional supplement use in athletes. Am. J. Sports Med. 30 (2002) 907-916
187. Seicean A., Redline S., Seicean S., Kirchner H.L., Gao Y., Sekine M., Zhu X., and Storfer-Isser A. Association between short sleeping hours and overweight in adolescents: results from a US Suburban High School survey. Sleep Breath. 11 (2007) 285-293
188. Shaham Y., Shalev U., Lu L., De Wit H., and Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl.) 168 (2003) 3-20
189. Sher K.J., Bartholow B.D., and Wood M.D. Personality and substance use disorders: a prospective study. J. Consult. Clin. Psychol. 68 (2000) 818-829
190. Shi J., Benowitz N.L., Denaro C.P., and Sheiner L.B. Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin. Pharmacol. Ther. 53 (1993) 6-14
191. Shoaib M., Swanner L.S., Yasar S., and Goldberg S.R. Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology (Berl.) 142 (1999) 327-333
192. Silverman K., Evans S.M., Strain E.C., and Griffiths R.R. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N. Engl. J. Med. 327 (1992) 1109-1114
193. Silverman K., and Griffiths R.R. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J. Exp. Anal. Behav. 57 (1992) 91-107
194. Sinclair C.J., and Geiger J.D. Caffeine use in sports. A pharmacological review. J. Sports Med. Phys. Fitness 40 (2000) 71-79
195. Smiciklas-Wright H., Mitchell D.C., Mickle S.J., Goldman J.D., and Cook A. Foods commonly eaten in the United States, 1989-1991 and 1994-1996: are portion sizes changing?. J. Am. Diet Assoc. 103 (2003) 41-47
196. Smit H.J., Cotton J.R., Hughes S.C., and Rogers P.J. Mood and cognitive performance effects of "energy" drink constituents: caffeine, glucose, and carbonation. Nutr. Neurosci. 7 (2004) 127-139
197. Smit H.J., and Rogers P.J. Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology (Berl.) 152 (2000) 167-173
198. Smith A. Effects of caffeine on human behavior. Food Chem. Toxicol. 40 (2002) 1243-1255
199. Sowell E.R., Thompson P.M., Holmes C.J., Jernigan T.L., and Toga A.W. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat. Neurosci. 2 (1999) 859-861
200. Srisuphan W., and Bracken M.B. Caffeine consumption during pregnancy and association with late spontaneous abortion. Am. J. Obstet. Gynecol. 154 (1986) 14-20
201. Stanton C.K., and Gray R.H. Effects of caffeine consumption on delayed conception. Am. J. Epidemiol. 142 (1995) 1322-1329
202. Stensvold I., Tverdal A., and Jacobsen B.K. Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ 312 (1996) 544-545
203. Stern K.N., Chait L.D., and Johanson C.E. Reinforcing and subjective effects of caffeine in normal human volunteers. Psychopharmacology (Berl.) 98 (1989) 81-88
204. Strain E.C., Mumford G.K., Silverman K., and Griffiths R.R. Caffeine dependence syndrome. Evidence from case histories and experimental evaluations. JAMA 272 (1994) 1043-1048
205. Sung B.H., Whitsett T.L., Lovallo W.R., al'Absi M., Pincomb G.A., and Wilson M.F. Prolonged increase in blood pressure by a single oral dose of caffeine in mildly hypertensive men. Am. J. Hypertens. 7 (1994) 755-758
206. Svenningsson P., Hall H., Sedvall G., and Fredholm B.B. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse 27 (1997) 322-335
207. Swanson J.A., Lee J.W., and Hopp J.W. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict. Behav. 19 (1994) 229-256
208. Szot P., Sanders R.C., and Murray T.F. Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology 26 (1987) 1173-1180
209. Tavani A., and La Vecchia C. Coffee, decaffeinated coffee, tea, and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes Control. 15 (2004) 743-757
210. Tchekalarova J., Kubova H., and Mares P. Effects of postnatal caffeine exposure on seizure susceptibility in developing rats. Brain Res. 1150 (2007) 32-39
211. Totten G.L., and France C.R. Physiological and subjective anxiety responses to caffeine and stress in nonclinical panic. J. Anxiety Disord. 9 (1995) 473-488
212. Tuomilehto J., Hu G., Bidel S., Lindstrom J., and Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291 (2004) 1213-1219
213. van Dam R.M., and Feskens E.J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360 (2002) 1477-1478
214. van Dam R.M., and Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294 (2005) 97-104
215. van Dam R.M., Willett W.C., Manson J.E., and Hu F.B. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabet. Care 29 (2006) 398-403
216. van Duinen H., Lorist M.M., and Zijdewind I. The effect of caffeine on cognitive task performance and motor fatigue. Psychopharmacology (Berl.) 180 (2005) 539-547
217. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 151 (2000) 99-120
218. Walsh M., Marquardt K., and Albertson T. Adverse effects from ingestion of Redline energy drinks. Clin. Toxicol. 44 (2006) 642
219. Warburton D.M., Bersellini E., and Sweeney E. An evaluation of a caffeinated taurine drink on mood, memory, and information processing in healthy volunteers without caffeine abstinence. Psychopharmacology 158 (2001) 322-328
220. Waring W.S., Goudsmit J., Marwick J., Webb D.J., and Maxwell S.R. Acute caffeine intake influences central more than peripheral blood pressure in young adults. Am. J. Hypertens. 16 (2003) 919-924
221. Watkinson B., and Fried P.A. Maternal caffeine use before, during, and after pregnancy and effects upon offspring. Neurobehav. Toxicol. Teratol. 7 (1985) 9-17
222. White F.J., and Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51 (1998) 141-153
223. Williams M.A., Monson R.R., Goldman M.B., Mittendorf R., and Ryan K.J. Coffee and delayed conception. Lancet 335 (1990) 1603
224. XSGear.com, 2007. XS Frequently asked questions. http://www.xsgear.com/support/faqs.asp. Accessed 29 September 2008.
225. Yeomans M.R., Spetch H., and Rogers P.J. Conditioned flavour preference negatively reinforced by caffeine in human volunteers. Psychopharmacology (Berl.) 137 (1998) 401-409
226. Yeomans M.R., Jackson A., Lee M.D., Nesic J., and Durlach P.J. Expression of flavour preferences conditioned by caffeine is dependent on caffeine deprivation state. Psychopharmacology (Berl.) 150 (2000) 208-215
227. Yeomans M.R., Jackson A., Lee M.D., Steer B., Tinley E., Durlach P., and Rogers P.J. Acquisition and extinction of flavour preferences conditioned by caffeine in humans. Appetite 35 (2000) 131-141
228. Yeomans M.R., Ripley T., Lee M.D., and Durlach P.J. No evidence for latent learning of liking for flavours conditioned by caffeine. Psychopharmacology (Berl.) 157 (2001) 172-179
229. Yeomans M.R., Pryke R., and Durlach P.J. Effect of caffeine-deprivation on liking for a non-caffeinated drink. Appetite 39 (2002) 35-42
230. Zheng G., Sayam K., Okubo T., Juneja L.R., and Oguni I. Anti-obesity effects of three major components of green tea, catechins, caffeine, and theanin, in mice. In Vivo 18 (2004) 55-62